Skip to main content

Table 1 Clinico-pathological parameters.

From: Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial

   Group A Group B Total
Parameters Age 58.5 ± 9.8 57.5 ± 16.3 58.0 ± 13.2
  Gender(male/females) 27/3 26/3 53/6
  BMI* 25.2 ± 3.8 24.8 ± 3.9 25.0 ± 3.8
Diagnosis Bronchiectasis 1 1 2
  Bullous disease 3 3 6
  Diaphragmatic tumors 0 1 1
  Empyema 4 4 8
  Esophageal achalasia 1 0 1
  Lung carcinoma 18 17 35
  Pulmonary metastases 2 2 4
  Thymoma 1 1 2
  Total 30 29 59
Co-morbitidy COPD 7 6 13
  Diabetes Mellitus 4 6 10
  Hypertension 7 9 16
  Serum Crea: 1.5–2.0 mg/dl 1 1 2
  Past history of cancer 2 1 3
  Coronary artery disease 3 3 6
  Extracardiac arteriopathy 1 1 2
  WBC's >15,000 mm/cm3 1 0 1
Pathology Primary lung carcinoma 18 17 35
  Other organ carcinoma 3 4 7
  Primary inflammatory disease 5 5 10
  Other 4 3 7
  Total 30 29 59
  1. *BMI: Body Mass Index.
  2. COPD = Chronic Obstructive Pulmonary Disease, WBC's = White Blood Count.